Zion Market Research, the market research group announced the analysis report titled “Cardiac Marker Testing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024”
Global Cardiac Marker Testing Market: Overview
When the heart is injured or stressed, it releases certain substances into the blood, which function as cardiac markers. The cardiac markers are usually enzymes, proteins, and hormones. Thus, quantification of these biomarkers can aid in diagnosing numerous heart disorders, including cardiac ischemia, acute coronary syndrome, and conditions linked to hindered blood supply to the heart. Physicians usually carry out multiple cardiac marker tests for hours to observe the blood level increase and to recognize the seriousness of a heart attack.
Global Cardiac Marker Testing Market: Growth Factors
The major factors boosting the growth of global cardiac marker testing include rising expenditure by different institutes to encourage clinical and research studies in biomarker testing, increasing incidence of cardiovascular disorders, and increasing elderly population. However, issues related to storage and collection of samples, compensation, and strict regulatory recommendation are few factors that can hamper the growth of the global market. In addition, estimation of cardiac marker levels in the labs requires considerable time; thus, it cannot be used in the determination of myocardial infarction during the acute phase further restraining its use.
Request Free Sample Report @ https://www.zionmarketresearch.com/sample/cardiac-marker-testing-market
Global Cardiac Marker Testing Market: Segmentation
The global market for cardiac marker testing can be segmented based on disease, type of testing, product, type, and region. The disease segment of the market is divided into congestive heart failure and myocardial infarction. The type of testing segment of the market is diversified into point-of-care testing and laboratory testing. The product segment of the cardiac marker testing market is classified into immunofluorescence, immunochromatography, instruments, reagents and kits, chemiluminescence, and enzyme-linked immunosorbent assay. The type segment of the market is divided into C-reactive protein, troponin I and T, brain natriuretic peptide or NT-proBNP, CK-MB, other biomarkers, and myoglobin. The other biomarkers segment of the market is classified into H-FABP, homocysteine, myeloperoxidase, galectin-3, and ischemia-modified albumin. Regionally, the cardiac marker testing market is diversified into North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Global Cardiac Marker Testing Market: Regional Analysis
North America is anticipated to dominate the global market of cardiac markers testing. The various factors contributing to the growth of the market in this region include rising aging population, increasing inclination toward point-of-care testing, and elevated frequency of cardiovascular disorders. Asia-Pacific region is also expected to grow in the global market in the near future owing to the huge population, growing incidence of chronic heart diseases, and various measures taken to increase alertness about the diagnosis of cardiac diseases at an early stage.
Global Cardiac Marker Testing Market: Competitive Players
The key players in the global cardiac marker testing market include Siemens AG, Abbott Laboratories, Danaher Corporation, bioMérieux SA, Alere, Inc., Roche Diagnostics Ltd., Ortho Clinical Diagnostics, LSI Medience Corporation, and Randox laboratories Ltd. The other major players in the global market are Guangzhou Wondfo Biotech Co., Ltd., Bio-Rad Laboratories, Inc., Helomics Corporation, Becton, Dickinson and Company, Avantra Biosciences, and Enzo Biochem.
Request Report TOC (Table of Contents) @ https://www.zionmarketresearch.com/toc/cardiac-marker-testing-market
Global Cardiac Marker Testing Market: Regional Segment Analysis
- North America
- Asia Pacific
- Latin America
- Middle East & Africa
What Report Provides
- Full in-depth analysis of the parent market
- Important changes in market dynamics
- Segmentation details of the market
- Former, on-going, and projected market analysis in terms of volume and value
- Assessment of niche industry developments
- Market share analysis
- Key strategies of major players
- Emerging segments and regional markets
- Testimonials to companies in order to fortify their foothold in the market.
Browse detail report @ https://www.zionmarketresearch.com/report/cardiac-marker-testing-market
Zion Market Research is an obligated company. We create futuristic, cutting edge, informative reports ranging from industry reports, company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
4283, Express Lane,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651